BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17429100)

  • 1. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
    Weder W; Stahel RA; Bernhard J; Bodis S; Vogt P; Ballabeni P; Lardinois D; Betticher D; Schmid R; Stupp R; Ris HB; Jermann M; Mingrone W; Roth AD; Spiliopoulos A;
    Ann Oncol; 2007 Jul; 18(7):1196-202. PubMed ID: 17429100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
    Flores RM; Krug LM; Rosenzweig KE; Venkatraman E; Vincent A; Heelan R; Akhurst T; Rusch VW
    J Thorac Oncol; 2006 May; 1(4):289-95. PubMed ID: 17409872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
    Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
    Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
    Krug LM; Pass HI; Rusch VW; Kindler HL; Sugarbaker DJ; Rosenzweig KE; Flores R; Friedberg JS; Pisters K; Monberg M; Obasaju CK; Vogelzang NJ
    J Clin Oncol; 2009 Jun; 27(18):3007-13. PubMed ID: 19364962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
    Weder W; Kestenholz P; Taverna C; Bodis S; Lardinois D; Jerman M; Stahel RA
    J Clin Oncol; 2004 Sep; 22(17):3451-7. PubMed ID: 15337794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    de Perrot M; Feld R; Cho BC; Bezjak A; Anraku M; Burkes R; Roberts H; Tsao MS; Leighl N; Keshavjee S; Johnston MR
    J Clin Oncol; 2009 Mar; 27(9):1413-8. PubMed ID: 19224855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
    Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience.
    Flores RM
    Lung Cancer; 2005 Jul; 49 Suppl 1():S71-4. PubMed ID: 15950805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
    Opitz I; Kestenholz P; Lardinois D; Müller M; Rousson V; Schneiter D; Stahel R; Weder W
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):579-84. PubMed ID: 16495068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
    Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
    J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.
    Rea F; Marulli G; Bortolotti L; Breda C; Favaretto AG; Loreggian L; Sartori F
    Lung Cancer; 2007 Jul; 57(1):89-95. PubMed ID: 17403553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma.
    Stewart DJ; Martin-Ucar A; Pilling JE; Edwards JG; O'Byrne KJ; Waller DA
    Ann Thorac Surg; 2004 Jul; 78(1):245-52. PubMed ID: 15223437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.
    Federico R; Adolfo F; Giuseppe M; Lorenzo S; Martino DT; Anna C; Adriano P; Gino C; Francesca R; Matteo C; Gbenga K; Paolo M; Francesco F
    BMC Cancer; 2013 Jan; 13():22. PubMed ID: 23324131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.
    Van Schil PE; Baas P; Gaafar R; Maat AP; Van de Pol M; Hasan B; Klomp HM; Abdelrahman AM; Welch J; van Meerbeeck JP;
    Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multimodality therapy for diffuse malignant pleural mesothelioma].
    Tomiyama K; Ishida H; Miyake M; Taki T
    Kyobu Geka; 2004 Oct; 57(11):1028-32. PubMed ID: 15510816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.